CERC-002
CERC-002-CVID-201
Phase 2 small_molecule completed
Quick answer
CERC-002 for COVID-19 Pneumonia is a Phase 2 program (small_molecule) at Avalo Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Avalo Therapeutics
- Indication
- COVID-19 Pneumonia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed